Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-blind, Multi-center Study to Compare the Immunological Efficacy and Safety of GC3102C With GC FLU Inj. Administered Intramuscularly in Healthy Adults

NCT01750814 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01750814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01750814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-blind, Multi-center Study to Compare the Immunological Efficacy and Safety of GC3102C With GC FLU Inj. Administered Intramuscularly in Healthy Adults
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2013
Completion date
July 31, 2013
Enrollment
400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prophylaxis against influenza